|
1.
|
DeSantis C, Siegel R, Bandi P and Jemal A:
Breast cancer statistics, 2011. CA Cancer J Clin. 61:409–418. 2011.
View Article : Google Scholar
|
|
2.
|
Ren W, Qiao Z, Wang H, Zhu L and Zhang L:
Flavonoids: promising anticancer agents. Med Res Rev. 23:519–534.
2003. View Article : Google Scholar
|
|
3.
|
Baowen Q, Yulin Z, Xin W, et al: A further
investigation concerning correlation between anti-fibrotic effect
of liposomal quercetin and inflammatory cytokines in pulmonary
fibrosis. Eur J Pharmacol. 642:134–139. 2010. View Article : Google Scholar
|
|
4.
|
Boots AW, Haenen GR and Bast A: Health
effects of quercetin: from antioxidant to nutraceutical. Eur J
Pharmacol. 585:325–337. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Murakami A, Ashida H and Terao J:
Multitargeted cancer prevention by quercetin. Cancer Lett.
269:315–325. 2008. View Article : Google Scholar
|
|
6.
|
Wei YQ, Zhao X, Kariya Y, Fukata H,
Teshigawara K and Uchida A: Induction of apoptosis by quercetin:
involvement of heat shock protein. Cancer Res. 54:4952–4957.
1994.PubMed/NCBI
|
|
7.
|
Yoshida M, Sakai T, Hosokawa N, et al: The
effect of quercetin on cell cycle progression and growth of human
gastric cancer cells. FEBS Lett. 260:10–13. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Choi EJ, Bae SM and Ahn WS:
Antiproliferative effects of quercetin through cell cycle arrest
and apoptosis in human breast cancer MDA-MB-453 cells. Arch Pharm
Res. 31:1281–1285. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Gulati N, Laudet B, Zohrabian VM, Murali R
and Jhanwar-Uniyal M: The antiproliferative effect of quercetin in
cancer cells is mediated via inhibition of the PI3K-Akt/PKB
pathway. Anticancer Res. 26:1177–1181. 2006.PubMed/NCBI
|
|
10.
|
Lee YK and Park OJ: Regulation of mutual
inhibitory activities between AMPK and Akt with quercetin in MCF-7
breast cancer cells. Oncol Rep. 24:1493–1497. 2010.PubMed/NCBI
|
|
11.
|
Eroles P, Bosch A, Perez-Fidalgo JA and
Lluch A: Molecular biology in breast cancer: intrinsic subtypes and
signaling pathways. Cancer Treat Rev. 38:698–707. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Grant S: Cotargeting survival signaling
pathways in cancer. J Clin Invest. 118:3003–3006. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Cai J, Guan H, Fang L, et al:
MicroRNA-374a activates Wnt/β-catenin signaling to promote breast
cancer metastasis. J Clin Invest. 123:566–579. 2013.PubMed/NCBI
|
|
14.
|
Lu W, Lin C, King TD, Chen H, Reynolds RC
and Li Y: Silibinin inhibits Wnt/beta-catenin signaling by
suppressing Wnt co-receptor LRP6 expression in human prostate and
breast cancer cells. Cell Signal. 24:2291–2296. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Wu Y, Ginther C, Kim J, et al: Expression
of Wnt3 activates Wnt/beta-catenin pathway and promotes EMT-like
phenotype in trastuzumab-resistant HER2-overexpressing breast
cancer cells. Mol Cancer Res. 10:1597–1606. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Tsukamoto AS, Grosschedl R, Guzman RC,
Parslow T and Varmus HE: Expression of the int-1 gene in transgenic
mice is associated with mammary gland hyperplasia and
adenocarcinomas in male and female mice. Cell. 55:619–625. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Clevers H: Wnt/beta-catenin signaling in
development and disease. Cell. 127:469–480. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Ryo A, Nakamura M, Wulf G, Liou YC and Lu
KP: Pin1 regulates turnover and subcellular localization of
beta-catenin by inhibiting its interaction with APC. Nat Cell Biol.
3:793–801. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Huang M, Wang Y, Sun D, et al:
Identification of genes regulated by Wnt/beta-catenin pathway and
involved in apoptosis via microarray analysis. BMC Cancer.
6:2212006. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Li Y, Welm B, Podsypanina K, et al:
Evidence that transgenes encoding components of the Wnt signaling
pathway preferentially induce mammary cancers from progenitor
cells. Proc Natl Acad Sci USA. 100:15853–15858. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Teissedre B, Pinderhughes A, Incassati A,
Hatsell SJ, Hiremath M and Cowin P: MMTV-Wnt1 and
-DeltaN89beta-catenin induce canonical signaling in distinct
progenitors and differentially activate Hedgehog signaling within
mammary tumors. PLoS One. 4:e45372009. View Article : Google Scholar
|
|
22.
|
Khramtsov AI, Khramtsova GF, Tretiakova M,
Huo D, Olopade OI and Goss KH: Wnt/beta-catenin pathway activation
is enriched in basal-like breast cancers and predicts poor outcome.
Am J Pathol. 176:2911–2920. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Lin SY, Xia W, Wang JC, et al:
Beta-catenin, a novel prognostic marker for breast cancer: its
roles in cyclin D1 expression and cancer progression. Proc Natl
Acad Sci USA. 97:4262–4266. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Aslakson CJ and Miller FR: Selective
events in the metastatic process defined by analysis of the
sequential dissemination of subpopulations of a mouse mammary
tumor. Cancer Res. 52:1399–1405. 1992.PubMed/NCBI
|
|
25.
|
Yoneda T, Michigami T, Yi B, Williams PJ,
Niewolna M and Hiraga T: Actions of bisphosphonate on bone
metastasis in animal models of breast carcinoma. Cancer.
88:2979–2988. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Choi JA, Kim JY, Lee JY, et al: Induction
of cell cycle arrest and apoptosis in human breast cancer cells by
quercetin. Int J Oncol. 19:837–844. 2001.PubMed/NCBI
|
|
27.
|
Avila MA, Velasco JA, Cansado J and
Notario V: Quercetin mediates the down-regulation of mutant p53 in
the human breast cancer cell line MDA-MB468. Cancer Res.
54:2424–2428. 1994.PubMed/NCBI
|
|
28.
|
Rodgers EH and Grant MH: The effect of the
flavonoids, quercetin, myricetin and epicatechin on the growth and
enzyme activities of MCF7 human breast cancer cells. Chem Biol
Interact. 116:213–228. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Brusselmans K, Vrolix R, Verhoeven G and
Swinnen JV: Induction of cancer cell apoptosis by flavonoids is
associated with their ability to inhibit fatty acid synthase
activity. J Biol Chem. 280:5636–5645. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Brennan KR and Brown AM: Wnt proteins in
mammary development and cancer. J Mammary Gland Biol Neoplasia.
9:119–131. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Giles RH, van Es JH and Clevers H: Caught
up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta.
1653:1–24. 2003.PubMed/NCBI
|
|
32.
|
Suzuki H, Toyota M, Carraway H, et al:
Frequent epigenetic inactivation of Wnt antagonist genes in breast
cancer. Br J Cancer. 98:1147–1156. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Bafico A, Liu G, Goldin L, Harris V and
Aaronson SA: An autocrine mechanism for constitutive Wnt pathway
activation in human cancer cells. Cancer Cell. 6:497–506. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Zhou XL, Qin XR, Zhang XD and Ye LH:
Downregulation of Dickkopf-1 is responsible for high proliferation
of breast cancer cells via losing control of Wnt/beta-catenin
signaling. Acta Pharmacol Sin. 31:202–210. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Qiao L, Xu ZL, Zhao TJ, Ye LH and Zhang
XD: Dkk-1 secreted by mesenchymal stem cells inhibits growth of
breast cancer cells via depression of Wnt signalling. Cancer Lett.
269:67–77. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Jeong JH, An JY, Kwon YT, Rhee JG and Lee
YJ: Effects of low dose quercetin: cancer cell-specific inhibition
of cell cycle progression. J Cell Biochem. 106:73–82. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Gibellini L, Pinti M, Nasi M, et al:
Quercetin and cancer chemoprevention. Evid Based Complement
Alternat Med. 2011:5913562011. View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Seo HS, Ju JH, Jang K and Shin I:
Induction of apoptotic cell death by phytoestrogens by
up-regulating the levels of phosphop53 and p21 in normal and
malignant estrogen receptor alpha-negative breast cells. Nutr Res.
31:139–146. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39.
|
Chou CC, Yang JS, Lu HF, et al:
Quercetin-mediated cell cycle arrest and apoptosis involving
activation of a caspase cascade through the mitochondrial pathway
in human breast cancer MCF-7 cells. Arch Pharm Res. 33:1181–1191.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
40.
|
Chien SY, Wu YC, Chung JG, et al:
Quercetin-induced apoptosis acts through mitochondrial- and
caspase-3-dependent pathways in human breast cancer MDA-MB-231
cells. Hum Exp Toxicol. 28:493–503. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
41.
|
Nusse R: Wnt signaling in disease and in
development. Cell Res. 15:28–32. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
42.
|
Lindvall C, Bu W, Williams BO and Li Y:
Wnt signaling, stem cells, and the cellular origin of breast
cancer. Stem Cell Rev. 3:157–168. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
43.
|
Anastas JN and Moon RT: WNT signalling
pathways as therapeutic targets in cancer. Nat Rev Cancer.
13:11–26. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
44.
|
Prosperi JR and Goss KH: A Wnt-ow of
opportunity: targeting the Wnt/beta-catenin pathway in breast
cancer. Curr Drug Targets. 11:1074–1088. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
45.
|
Chim CS, Pang R, Fung TK, Choi CL and
Liang R: Epigenetic dysregulation of Wnt signaling pathway in
multiple myeloma. Leukemia. 21:2527–2536. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
46.
|
Matsuda Y, Schlange T, Oakeley EJ, Boulay
A and Hynes NE: WNT signaling enhances breast cancer cell motility
and blockade of the WNT pathway by sFRP1 suppresses MDA-MB-231
xenograft growth. Breast Cancer Res. 11:R322009. View Article : Google Scholar : PubMed/NCBI
|
